Zero Candida Ltd (TSX-V:ZCT) announced that its shares are now listed on the Frankfurt Stock Exchange (FSE) under the ticker symbol “9L2.”
The company is now listed on both the TSX Venture Exchange and the FSE, providing increased visibility and access to more international investors.
"Listing on the Frankfurt Stock Exchange represents a crucial step forward for Zero Candida. The European investment community has been captivated by our innovations from the start, and this listing allows them to directly be a part of our vision and growth journey,” Eli Ben Haroosh, Zero Candida’s CEO said.
“With our hospital partnerships and patent applications progressing across Europe, we're thrilled to expand our capital markets presence and accelerate our mission of revolutionizing women's health."
Further, the company said it will be hosting an inaugural webinar for shareholders on Wednesday, January 22 at 1pm Eastern Time.
The Zero Candida team will present updates on the development of their innovative device and technology, share a corporate overview, and highlight key milestones planned for 2025, concluding with a Q&A session.
Interested parties can register for the event here.